BioStem Technologies Reports Q1 2026 Revenue Drop Amid Strategic Shift to Hospital Market
BioStem Technologies reports Q1 2026 revenue of $6.1M, driven by Neox and Clarix products. The company focuses on hospital market, expands sales force, and progresses
2026/05/15